We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 9,467 results
  1. Adverse drug reactions associated with COVID-19 management

    The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak, which causes COVID-19, had a devastating impact on both...

    Vivek Chavda, Payal Dodiya, Vasso Apostolopoulos in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 14 May 2024
  2. A highlight on carbamazepine-induced adverse drug reactions in Saudi Arabia: a retrospective medical records-based study

    The link between human leukocyte antigen (HLA) alleles and carbamazepine-induced cutaneous, respiratory, and gastrointestinal adverse drug reactions...

    Hatouf H. Sukkarieh, Ayesha A. Khokhar, ... Syed N. Alvi in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 18 May 2023
  3. Influence of pharmacogenomic polymorphisms on allopurinol-induced cutaneous adverse drug reactions in Thai patients

    Background

    Allopurinol has been causing substantial morbidity and mortality particularly in Asian population by producing cutaneous adverse drug...

    Gaidganok Sornsamdang, Patompong Satapornpong, ... Chonlaphat Sukasem in BMC Medical Genomics
    Article Open access 23 April 2024
  4. The relationship between medication literacy and skin adverse reactions in non-small-cell lung cancer patients undergoing targeted EGFR-TKI therapy

    Background

    High medication literacy is the basis of rational medication application and is essential for the management of severe adverse drug...

    Ruofei Du, Huashan Yang, ... Tao Wang in BMC Cancer
    Article Open access 03 May 2022
  5. Avoidance of cutaneous adverse drug reactions induced by antiepileptic drugs based on pharmacogenomics

    Pharmacogenomics (PGx) is a research area aimed at identifying genetic factors that are associated with drug responses, including drug efficacy,...

    Taisei Mushiroda in Journal of Human Genetics
    Article 09 May 2022
  6. Safety analysis of therapeutic drugs for breast cancer patients and construction of a predictive model for serious adverse drug reactions

    Objectives

    To explore the characteristics of the occurrence of antineoplastic drug adverse reactions (ADRs) in breast cancer and to utilize a...

    Shuzhi Lin, Shuang Lei, ... Bianling Feng in European Journal of Clinical Pharmacology
    Article 15 December 2023
  7. Adverse drug reactions of Rituximab in patients suffering from autoimmune neurological diseases

    Background

    Rituximab, a chimeric human/mouse monoclonal antibody targeting CD-20 antigens, has been used recently for various rheumatological and...

    Niayesh Mohebbi, Maryam Taghizadeh-Ghehi, ... Shahriar Nafissi in DARU Journal of Pharmaceutical Sciences
    Article 24 September 2022
  8. Pharmacovigilance of cutaneous adverse drug reactions in associations with drugs and medical conditions: a retrospective study of hospitalized patients

    Background

    Cutaneous adverse drug reaction (CADR) is a common problem in clinical medication. This study aimed to investigate the correlation between...

    Lei Zheng, Hao-bin **, ... **g Yang in BMC Pharmacology and Toxicology
    Article Open access 10 August 2022
  9. Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System

    Introduction

    Anti-calcitonin gene-related peptide monoclonal antibodies (anti-CGRP-mAbs) have recently been approved for the prevention of migraine,...

    Emanuela Elisa Sorbara, Maria Antonietta Barbieri, ... Edoardo Spina in BioDrugs
    Article 25 February 2024
  10. Drug Allergy and Cutaneous Adverse Reactions

    Allergy or hypersensitivity to drugs often affects the skin and sometimes also mucosa. While immediate type reactions show a rather homogeneous...
    Chapter 2021
  11. Development and application of Adverse drug reactions reports QUality Algorithm (AQUA-12) score: a single-centre quality improvement initiative

    Purpose

    To develop a reliable assessment tool to monitor the quality of adverse drug reaction (ADR) reports and evaluate its performance within a...

    Ar Kar Aung, Celia M. Zubrinich, ... Linda V. Graudins in European Journal of Clinical Pharmacology
    Article Open access 20 February 2023
  12. Adverse drug reactions to chloroquine/hydroxychloroquine in combination with azithromycin in COVID-19 in-patients: data from intensive pharmacovigilance in Morocco, 2020

    In Morocco, chloroquine/hydroxychloroquine + azithromycin have been used off-label for COVID-19 treatment. This study aimed to describe the...

    Latifa Aït Moussa, Amina Tebaa, ... Rachida Soulaymani Bencheikh in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 26 June 2023
  13. The Immunogenetics of Cutaneous Drug Reactions

    Adverse drug reactions (ADRs) areAdverse drug reactions the cause of nearly three to six percent of inpatient admissions and are associated with high...
    Chapter 2022
  14. Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database

    Background

    The management of uncontrolled severe asthma has greatly improved since the advent of novel biologic therapies. Up to August 2022, five...

    Paola Maria Cutroneo, Elena Arzenton, ... Gianluca Trifirò in BioDrugs
    Article Open access 15 March 2024
  15. Efficacy of aluminum chloride in severe regorafenib-associated hand-foot skin reactions: a single-arm trial

    Background

    Regorafenib, a multikinase inhibitor, causes a high frequency of hand-foot skin reactions (HFSRs). The present study evaluated the efficacy...

    Aya Nishizawa, Eiji Shinozaki, ... Kensei Yamaguchi in BMC Cancer
    Article Open access 04 May 2023
  16. Chitosan-based drug delivery systems for skin atopic dermatitis: recent advancements and patent trends

    Atopic dermatitis (AD) is a complex, relapsing inflammatory skin disease with a considerable social and economic burden globally. AD is primarily...

    Lay-Hong Chuah, Hooi-Leong Loo, ... Shiow-Fern Ng in Drug Delivery and Translational Research
    Article 17 February 2023
  17. Relationship of cytochrome P450 gene polymorphisms with blood concentrations of hydroxychloroquine and its metabolites and adverse drug reactions

    Background

    Hydroxychloroquine (HCQ) is a cornerstone therapy for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). This study aimed to...

    Beibei Gao, Tingfei Tan, ... Quan **a in BMC Medical Genomics
    Article Open access 08 February 2022
  18. Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma

    Skin cutaneous melanoma (SKCM) has a low early detection rate and a high mortality rate. There are many problems such as side effects and drug...

    Shengyong Long, **g Xu, Hai Huang in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 22 April 2023
  19. Macrolides in Chronic Skin Disorders

    Macrolide antibiotics are widely used to treat infections of soft tissues and the respiratory tract due to their efficacy against Gram-negative and...
    Chapter 2024
  20. Silymarin as a preventive or therapeutic measure for chemotherapy and radiotherapy-induced adverse reactions: a comprehensive review of preclinical and clinical data

    Purpose

    Thus far, silymarin has been examined in several studies for prevention or treatment of various chemotherapy or radiotherapy-induced adverse...

    Mahsa Ghodousi, Hedyieh Karbasforooshan, ... Sepideh Elyasi in European Journal of Clinical Pharmacology
    Article 01 December 2022
Did you find what you were looking for? Share feedback.